ValeurQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26TTMFrais de vente, généraux et administratifs595.2 M546 M579.3 M552.4 M538.6 M551 M2.22 BRecherche et développement———————Résultat d'exploitation216.5 M326 M394.5 M396.6 M267.6 M380.8 M1.44 BTotal des produits hors exploitation31.2 M5.5 M-31 M1.6 M-16.1 M-900 K-46.4 MCharges d'intérêts, nettes des intérêts capitalisés63.4 M56 M57.1 M56 M55 M55.1 M223.2 MRésultat hors exploitation, hors charges d'intérêts-48.6 M-49.5 M-55.4 M-52.5 M-51.7 M-42.9 M-202.5 MRevenus/dépenses exceptionnels16.4 M-1 M-32.7 M-1.9 M-19.4 M-13.1 M-67.1 MRésultat avant impôts958.8 M2.73 B2.88 B2.94 B1.1 B2.91 B9.82 BPart des actionnaires dans le résultat-700 K-300 K-1.7 M-5.2 M-6.1 M-5.1 M-18.1 MImpôts40.2 M62.2 M66.4 M75.5 M25.7 M41.7 M209.3 MIntérêts ne donnant pas le contrôle / intérêts minoritaires200 K200 K400 K400 K200 K200 K1.2 MAutres produits/charges après impôts———————Résultat net avant activités abandonnées143.4 M212.8 M237.9 M261.1 M164.7 M277.8 M941.5 MActivités abandonnées0———0——Résultat net143.4 M212.8 M237.9 M261.1 M164.7 M277.8 M941.5 MAjustement de dilution———————Dividendes privilégiés———————Résultat net dilué revenant aux actionnaires ordinaires143.4 M212.8 M237.9 M261.1 M164.7 M277.8 M941.5 MBénéfice par action de base (BPA de base)1.722.542.853.142.013.3711.37Bénéfice par action dilué (BPA dilué)1.722.522.843.121.983.3511.29Nombre moyen d'actions de base en circulation83.9 M83.6 M83.4 M83.1 M83.2 M82.3 M—Nombre d'actions en circulation après dilution84.4 M84.3 M83.9 M83.7 M83.8 M82.9 M—EBITDA214 M504.1 M568.9 M574.9 M340.8 M560.6 M2.05 BEBIT53.2 M327.5 M398.6 M403.9 M167.8 M387.3 M1.36 BCoût des ventes2.43 B2.4 B2.48 B2.54 B2.52 B2.52 B10.07 BAutres coûts des ventes———————Amortissements (flux de trésorerie)170.6 M166.8 M170.3 M171 M173 M173.3 M687.6 M
Labcorp Holdings Inc. Common Stock
Labcorp Holdings Inc., operating under the brand name Labcorp, headquartered in Burlington, North Carolina, provides laboratory services used for diagnosis and healthcare decisions. It operates one of the largest clinical laboratory networks in the world and has operations in over 100 countries; although its operations are primarily in the U.S.
Its Diagnostics Laboratories segment operates 2,000 patient service centers with more than 6,000 in-office phlebotomists in the United States. In addition to healthcare testing such as oncology testing, human immunodeficiency virus genotyping and phenotyping, it provides testing for: employment, DNA testing to determine parentage and to determine immigration eligibility, environmental issues, wellness, toxicology, pain management, and medical drug monitoring. It also provides 50 tests that patients can complete at home. It processes over 160 million tests per year. Approximately 10% of this segment’s revenue are from the U.S. Medicare health insurance program.